Obstructive sleep apnoe and cardiovascular, heart failure and mortality outcomes with empagliflozin versus placebo in the EMPA-REG OUTCOME trial
Event:
ESC Congress 2020
Topic:
Sleep Apnoea
Session:
Sleep Disordered Breathing and Cardiovascular Disease: from Evidence to Experience
